BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7175732)

  • 1. Theophylline bioavailability in the dog.
    Tse FL; Szeto DW
    J Pharm Sci; 1982 Nov; 71(11):1301-3. PubMed ID: 7175732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beagle dog as an animal model for a bioavailability study of controlled-release theophylline under the influence of food.
    Shiu GK; LeMarchand A; Sager AO; Velagapudi RB; Skelly JP
    Pharm Res; 1989 Dec; 6(12):1039-42. PubMed ID: 2622858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic studies of theophylline in dogs.
    McKiernan BC; Neff-Davis CA; Koritz GD; Davis LE; Pheris DR
    J Vet Pharmacol Ther; 1981 Jun; 4(2):103-10. PubMed ID: 7349323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline absorption and disposition in rabbits: oral, intravenous, and concentration-dependent kinetic studies.
    El-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1981 Apr; 70(4):452-6. PubMed ID: 7229966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.
    Fixley M; Shen DD; Azarnoff DL
    Am Rev Respir Dis; 1977 Jun; 115(6):955-62. PubMed ID: 262107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of gastrointestinal physiology regulated-dogs: bioavailability study of a commercial sustained-release dosage form of theophylline.
    Sagara K; Kawata M; Mizuta H; Shibata M
    Biol Pharm Bull; 1994 Jul; 17(7):931-4. PubMed ID: 8000380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.
    Sansom LN; Milne RW; Cooper D
    Eur J Clin Pharmacol; 1979; 16(6):417-21. PubMed ID: 583332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bioavailability of theophylline in horses.
    Errecalde JO; Button C; Baggot JD; Mulders MS
    J Vet Pharmacol Ther; 1984 Dec; 7(4):255-63. PubMed ID: 6512916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
    Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic studies of theophylline in horses.
    Ingvast-Larsson C; Paalzow G; Paalzow L; Ottosson T; Lindholm A; Appelgren LE
    J Vet Pharmacol Ther; 1985 Mar; 8(1):76-81. PubMed ID: 3989903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Theophylline: pharmacokinetics, metabolism and urinary excretion in dogs].
    Kuze T; Miyazaki H; Taneike T
    Nihon Yakurigaku Zasshi; 1988 May; 91(5):325-34. PubMed ID: 3410380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of caffeine on circulating theophylline levels in beagle dogs.
    Tse FL; Valia KH; Szeto DW; Raimondo TJ; Koplowitz B
    J Pharm Sci; 1981 Apr; 70(4):395-9. PubMed ID: 7229951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the absorption from some commercial sustained-release theophylline products.
    Upton RA; Thiercelin JF; Guentert TW; Sansom L; Powell JR; Coates PE; Riegelman S
    J Pharmacokinet Biopharm; 1980 Apr; 8(2):131-49. PubMed ID: 7431219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.
    Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
    Arzneimittelforschung; 1984; 34(1):92-5. PubMed ID: 6538428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of theophylline following enema and suppository administration in man.
    Cole ML; Kunka RL
    Biopharm Drug Dispos; 1984; 5(3):229-40. PubMed ID: 6548392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and pharmacokinetics in man of orally administered theophylline.
    Nielsen-Kudsk F; Magnussen I; Jensen TS; Naeser K
    Acta Pharmacol Toxicol (Copenh); 1980 Mar; 46(3):205-12. PubMed ID: 7361576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A crossover study after oral and intravenous administration of theophylline in male volunteers (absolute bioavailability of Afonilum tablets).
    Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):339-45. PubMed ID: 6885204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.